Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

2.

A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.

Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW.

J Immunol. 2004 Mar 15;172(6):3678-85.

3.

CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.

Wuttge DM, Zhou X, Sheikine Y, Wågsäter D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjö A.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):750-5. Epub 2004 Feb 26.

4.

Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.

Scholz F, Schulte A, Adamski F, Hundhausen C, Mittag J, Schwarz A, Kruse ML, Proksch E, Ludwig A.

J Invest Dermatol. 2007 Jun;127(6):1444-55. Epub 2007 Mar 15.

5.

Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.

Aslanian AM, Charo IF.

Circulation. 2006 Aug 8;114(6):583-90. Epub 2006 Jul 31.

6.

The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.

Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A.

J Immunol. 2004 May 15;172(10):6362-72.

7.

CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Gutwein P, Abdel-Bakky MS, Schramme A, Doberstein K, Kämpfer-Kolb N, Amann K, Hauser IA, Obermüller N, Bartel C, Abdel-Aziz AA, El Sayed el SM, Pfeilschifter J.

Am J Pathol. 2009 Jun;174(6):2061-72. doi: 10.2353/ajpath.2009.080960. Epub 2009 May 12.

8.

CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.

Gutwein P, Abdel-Bakky MS, Doberstein K, Schramme A, Beckmann J, Schaefer L, Amann K, Doller A, Kämpfer-Kolb N, Abdel-Aziz AA, El Sayed el SM, Pfeilschifter J.

J Cell Mol Med. 2009 Sep;13(9B):3809-25. doi: 10.1111/j.1582-4934.2009.00761.x. Epub 2009 May 1.

9.

Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.

Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S.

J Leukoc Biol. 2004 Feb;75(2):267-74. Epub 2003 Nov 21.

PMID:
14634054
10.

Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.

Hu ZB, Chen Y, Gong YX, Gao M, Zhang Y, Wang GH, Tang RN, Liu H, Liu BC, Ma KL.

Int J Med Sci. 2016 Oct 20;13(11):858-867. eCollection 2016.

11.

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.

Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.

Cancer Res. 2008 Jun 15;68(12):4701-8. doi: 10.1158/0008-5472.CAN-08-0482. Retraction in: Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E. Cancer Res. 2011 Feb 1;71(3):1196.

12.

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.

Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, Johannsen M, Jung K, Schaider H, Altevogt P, Ludwig A, Pfeilschifter J, Kristiansen G.

Eur J Cancer. 2009 Feb;45(3):478-89. doi: 10.1016/j.ejca.2008.10.023. Epub 2008 Dec 11.

PMID:
19070478
14.

Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo.

Postea O, Koenen RR, Hristov M, Weber C, Ludwig A.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1700-9. doi: 10.1111/j.1582-4934.2008.00223.x. Epub 2008 Jan 11.

15.

Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes.

Hundhausen C, Schulte A, Schulz B, Andrzejewski MG, Schwarz N, von Hundelshausen P, Winter U, Paliga K, Reiss K, Saftig P, Weber C, Ludwig A.

J Immunol. 2007 Jun 15;178(12):8064-72.

16.

The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.

Schramme A, Abdel-Bakky MS, Kämpfer-Kolb N, Pfeilschifter J, Gutwein P.

Biochem Biophys Res Commun. 2008 May 30;370(2):311-6. doi: 10.1016/j.bbrc.2008.03.088. Epub 2008 Mar 26.

PMID:
18373975
17.

Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.

Lv Y, Hou X, Ti Y, Bu P.

Clin Nutr. 2013 Oct;32(5):849-54. doi: 10.1016/j.clnu.2013.01.008. Epub 2013 Jan 23.

PMID:
23398954
18.

CXCL16/SR-PSOX--a friend or a foe in atherosclerosis?

Sheikine Y, Sirsjö A.

Atherosclerosis. 2008 Apr;197(2):487-95. doi: 10.1016/j.atherosclerosis.2007.11.034. Epub 2008 Jan 14. Review.

PMID:
18191863
20.

Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases.

Schulte A, Schulz B, Andrzejewski MG, Hundhausen C, Mletzko S, Achilles J, Reiss K, Paliga K, Weber C, John SR, Ludwig A.

Biochem Biophys Res Commun. 2007 Jun 22;358(1):233-40. Epub 2007 Apr 24.

PMID:
17467666

Supplemental Content

Support Center